If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

ATRA Insider Trading (Atara Biotherapeutics)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.00%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $1,569,092.68

Atara Biotherapeutics Insider Trading History Chart

Atara Biotherapeutics Share Price & Price History

^$4.94

▼ -0.4 (-7.49%)

As of 08/16/2022 01:00 AM ET

Days: 30 | 90 | 365

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

Atara Biotherapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/27/2022	Pascal Touchon	CEO	Sell	14,220	$7.20	$102,384.00	472,093
5/17/2022	K. Amar Murugan	SVP	Sell	3,223	$5.32	$17,146.36	133,735
5/17/2022	Jakob Dupont	EVP	Sell	3,873	$5.32	$20,604.36	163,006
5/17/2022	Pascal Touchon	CEO	Sell	13,913	$5.32	$74,017.16	486,313
5/17/2022	Utpal Koppikar	CFO	Sell	5,582	$5.32	$29,696.24	207,592
2/10/2022	Jakob Dupont	EVP	Sell	5,000	$16.00	$80,000.00
2/7/2022	Utpal Koppikar	CFO	Sell	2,496	$14.46	$36,092.16
11/16/2021	K. Amar Murugan	SVP	Sell	2,124	$17.12	$36,362.88
11/16/2021	Jakob Dupont	EVP	Sell	2,199	$17.12	$37,646.88
11/16/2021	Pascal Touchon	CEO	Sell	8,402	$17.12	$143,842.24
11/16/2021	Utpal Koppikar	CFO	Sell	3,655	$17.12	$62,573.60
11/15/2021	Joe Newell	Insider	Sell	7,000	$17.71	$123,970.00
11/4/2021	Matthew K. Fust	Director	Sell	13,354	$19.50	$260,403.00
11/2/2021	Jakob Dupont	EVP	Sell	5,000	$16.41	$82,050.00
9/22/2021	Joe Newell	Insider	Sell	10,500	$17.00	$178,500.00
8/30/2021	Joe Newell	Insider	Sell	3,500	$15.00	$52,500.00	123,045
8/17/2021	K. Amar Murugan	SVP	Sell	2,080	$12.53	$26,062.40	89,664
8/17/2021	Jakob Dupont	EVP	Sell	2,152	$12.53	$26,964.56	92,793
8/17/2021	Joe Newell	Insider	Sell	2,426	$12.53	$30,397.78	126,545
8/17/2021	Pascal Touchon	CEO	Sell	8,223	$12.53	$103,034.19	336,891
8/17/2021	Utpal Koppikar	CFO	Sell	3,579	$12.53	$44,844.87	161,369
6/14/2021	Kristin Yarema	Insider	Buy	32,333	$14.57	$471,091.81	93,549
6/11/2021	Kristin Yarema	Insider	Buy	2,021	$14.50	$29,304.50	93,549
6/8/2021	Utpal Koppikar	CFO	Sell	5,820	$14.06	$81,829.20
5/17/2021	Joe Newell	Insider	Sell	3,500	$15.00	$52,500.00	131,424
3/26/2021	Joe Newell	Insider	Sell	2,640	$14.58	$38,491.20	135,579
3/26/2021	Utpal Koppikar	CFO	Sell	1,761	$14.58	$25,675.38	172,582
3/15/2021	Joe Newell	COO	Sell	7,000	$17.41	$121,870.00	145,219
2/8/2021	Joe Newell	Insider	Sell	3,886	$20.39	$79,235.54	105,669
2/8/2021	Utpal Koppikar	CFO	Sell	1,759	$20.39	$35,866.01
1/15/2021	Joe Newell	Insider	Sell	7,000	$18.84	$131,880.00	116,555
12/16/2020	Joe Newell	Insider	Sell	7,000	$23.11	$161,770.00	120,055
11/13/2020	Joe Newell	COO	Sell	7,500	$18.49	$138,675.00
8/18/2020	Joe Newell	Insider	Sell	1,678	$12.09	$20,287.02	122,203
8/18/2020	Pascal Touchon	CEO	Sell	4,807	$12.09	$58,116.63	260,037
8/18/2020	Utpal Koppikar	CFO	Sell	1,496	$12.09	$18,086.64	133,530
6/25/2020	Pascal Touchon	CEO	Sell	12,135	$12.92	$156,784.20	264,844
4/6/2020	Joe Newell	Insider	Sell	657	$7.94	$5,216.58	125,484
3/27/2020	Joe Newell	Insider	Sell	2,740	$9.17	$25,125.80	126,141
3/27/2020	Utpal Koppikar	CFO	Sell	1,827	$9.17	$16,753.59	137,330
2/6/2020	Joe Newell	Insider	Sell	4,117	$14.21	$58,502.57	53,881
2/6/2020	Utpal Koppikar	CFO	Sell	1,781	$14.21	$25,308.01	72,282
9/27/2019	Joe Newell	Insider	Sell	3,500	$13.51	$47,285.00	57,998

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

SEC Filings (Institutional Ownership Changes) for Atara Biotherapeutics (NASDAQ:ATRA)

Institutional Buying and Selling by Quarter

Atara Biotherapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/16/2022	Josh Arnold Investment Consultant LLC	30,000	$0.23M	0.3%	N/A	0.032%
8/16/2022	Thrivent Financial for Lutherans	73,642	$0.57M	0.0%	N/A	0.078%
8/16/2022	Price T Rowe Associates Inc. MD	44,115	$0.34M	0.0%	+53.8%	0.047%
8/16/2022	Caption Management LLC	52,000	$0.41M	0.0%	N/A	0.055%
8/15/2022	State Street Corp	6,221,686	$48.47M	0.0%	-0.8%	6.593%
8/15/2022	Cubist Systematic Strategies LLC	25,700	$0.20M	0.0%	-63.4%	0.027%
8/15/2022	Millennium Management LLC	63,002	$0.49M	0.0%	-85.8%	0.067%
8/15/2022	Eminence Capital LP	1,323,075	$10.31M	0.2%	-3.3%	1.402%
8/13/2022	Quantbot Technologies LP	13,642	$0.11M	0.0%	N/A	0.014%
8/13/2022	Teacher Retirement System of Texas	12,095	$94K	0.0%	-21.7%	0.013%
8/13/2022	Renaissance Technologies LLC	225,200	$1.75M	0.0%	-60.5%	0.239%
8/12/2022	Northern Trust Corp	868,005	$6.76M	0.0%	+4.3%	0.920%
8/12/2022	Virtus ETF Advisers LLC	20,097	$0.16M	0.1%	+103.7%	0.021%
8/12/2022	Ensign Peak Advisors Inc	227,527	$1.77M	0.0%	+39.1%	0.241%
8/12/2022	Credit Suisse AG	60,434	$0.47M	0.0%	-6.7%	0.064%
8/12/2022	B. Metzler seel. Sohn & Co. AG	16,121	$0.13M	0.0%	N/A	0.017%
8/12/2022	FMR LLC	5,846,060	$45.54M	0.0%	+1.7%	6.195%
8/12/2022	BNP Paribas Arbitrage SA	26,885	$0.21M	0.0%	+101.6%	0.028%
8/12/2022	Franklin Resources Inc.	20,467	$0.16M	0.0%	-32.7%	0.022%
8/12/2022	Rhumbline Advisers	139,185	$1.08M	0.0%	+16.6%	0.149%
8/11/2022	Healthcare of Ontario Pension Plan Trust Fund	616,900	$4.81M	0.0%	N/A	0.654%
8/11/2022	UBS Group AG	40,818	$0.32M	0.0%	-83.6%	0.043%
8/11/2022	Bank of Montreal Can	153,799	$1.10M	0.0%	N/A	0.163%
8/11/2022	JPMorgan Chase & Co.	8,861,252	$69.03M	0.0%	+8.2%	9.391%
8/10/2022	Principal Financial Group Inc.	16,023	$0.12M	0.0%	N/A	0.017%
8/9/2022	Swiss National Bank	186,400	$1.45M	0.0%	+4.9%	0.200%
8/5/2022	Connor Clark & Lunn Investment Management Ltd.	104,898	$0.82M	0.0%	+128.8%	0.112%
8/5/2022	Staley Capital Advisers Inc.	425,000	$3.31M	0.2%	+41.7%	0.455%
8/4/2022	Mitsubishi UFJ Kokusai Asset Management Co. Ltd.	48,022	$0.37M	0.0%	+178.8%	0.051%
8/3/2022	Integral Health Asset Management LLC	208,738	$1.63M	0.3%	-30.4%	0.223%
8/1/2022	ProShare Advisors LLC	17,587	$0.14M	0.0%	-32.2%	0.019%
7/29/2022	SG Americas Securities LLC	67,211	$0.52M	0.0%	-67.4%	0.072%
7/27/2022	Assenagon Asset Management S.A.	606,269	$4.72M	0.0%	-16.9%	0.649%
7/26/2022	Mirae Asset Global Investments Co. Ltd.	27,000	$0.21M	0.0%	N/A	0.029%
7/19/2022	Hennion & Walsh Asset Management Inc.	228,532	$1.78M	0.1%	+46.0%	0.245%
7/13/2022	Trellus Management Company LLC	110,000	$0.86M	1.0%	+15.8%	0.118%
6/7/2022	Bank of America Corp DE	186,386	$1.73M	0.0%	+50.5%	0.200%
5/27/2022	Walleye Capital LLC	31,847	$0.30M	0.0%	N/A	0.034%
5/18/2022	BNP Paribas Arbitrage SA	13,338	$0.12M	0.0%	-72.9%	0.014%
5/17/2022	Walleye Capital LLC	31,847	$0.30M	0.0%	N/A	0.034%
5/17/2022	Point72 Hong Kong Ltd	7,234	$67K	0.0%	+343.8%	0.008%
5/17/2022	Royal Bank of Canada	25,962	$0.24M	0.0%	+8.4%	0.028%
5/17/2022	Eminence Capital LP	1,367,710	$12.71M	0.1%	+19.8%	1.464%
5/17/2022	Ensign Peak Advisors Inc	163,567	$1.52M	0.0%	+812.8%	0.175%
5/16/2022	California State Teachers Retirement System	101,845	$0.95M	0.0%	-5.9%	0.109%
5/16/2022	Goldman Sachs Group Inc.	3,638,106	$33.80M	0.0%	+41.9%	3.895%
5/16/2022	PDT Partners LLC	37,030	$0.34M	0.0%	-68.7%	0.040%
5/16/2022	State Street Corp	6,273,617	$58.28M	0.0%	+45.1%	6.717%
5/16/2022	Engineers Gate Manager LP	16,400	$0.15M	0.0%	-64.1%	0.018%
5/16/2022	Vident Investment Advisory LLC	74,844	$0.70M	0.0%	+19.6%	0.080%
5/16/2022	Invesco Ltd.	64,934	$0.60M	0.0%	+38.0%	0.070%
5/16/2022	UBS Group AG	249,283	$2.32M	0.0%	+1.5%	0.267%
5/13/2022	Renaissance Technologies LLC	569,800	$5.29M	0.0%	N/A	0.610%
5/13/2022	Baupost Group LLC MA	8,123,616	$75.47M	0.8%	-4.2%	8.697%
5/13/2022	Northern Trust Corp	831,952	$7.73M	0.0%	-3.3%	0.891%
5/13/2022	Charles Schwab Investment Management Inc.	641,875	$5.96M	0.0%	+4.1%	0.687%
5/13/2022	Wasatch Advisors Inc.	3,823,588	$35.52M	0.2%	+88.8%	4.094%
5/13/2022	Arrowstreet Capital Limited Partnership	42,793	$0.40M	0.0%	N/A	0.046%
5/13/2022	XTX Topco Ltd	23,282	$0.22M	0.1%	N/A	0.025%
5/13/2022	American International Group Inc.	43,148	$0.40M	0.0%	-6.6%	0.046%
5/13/2022	Vanguard Group Inc.	6,912,574	$64.22M	0.0%	-2.3%	7.400%
5/13/2022	Canada Pension Plan Investment Board	104,000	$0.97M	0.0%	-42.9%	0.111%
5/13/2022	M28 Capital Management LP	389,353	$3.62M	3.3%	-14.8%	0.417%
5/13/2022	Dimensional Fund Advisors LP	1,340,251	$12.45M	0.0%	+9.5%	1.435%
5/12/2022	Staley Capital Advisers Inc.	300,000	$2.79M	0.1%	+20.0%	0.321%
5/12/2022	Integral Health Asset Management LLC	300,000	$2.79M	0.7%	+50.0%	0.321%
5/12/2022	BlackRock Inc.	7,800,139	$72.46M	0.0%	-0.2%	8.351%
5/12/2022	Rhumbline Advisers	119,354	$1.11M	0.0%	-6.8%	0.128%
5/12/2022	Metropolitan Life Insurance Co NY	5,666	$53K	0.0%	-74.9%	0.006%
5/12/2022	MetLife Investment Management LLC	46,683	$0.43M	0.0%	+56.9%	0.050%
5/12/2022	Monashee Investment Management LLC	10,000	$93K	0.0%	N/A	0.011%
5/12/2022	Artal Group S.A.	1,000,000	$9.29M	0.4%	-33.3%	1.071%
5/12/2022	E Fund Management Co. Ltd.	19,420	$0.18M	0.0%	N/A	0.021%
5/12/2022	AlphaCrest Capital Management LLC	21,300	$0.20M	0.0%	+77.7%	0.023%
5/12/2022	Citigroup Inc.	865,144	$8.04M	0.0%	-14.6%	0.926%
5/12/2022	Running Point Capital Advisors LLC	10,000	$93K	0.1%	N/A	0.011%
5/12/2022	Connor Clark & Lunn Investment Management Ltd.	45,847	$0.43M	0.0%	+148.1%	0.049%
5/11/2022	Bank of New York Mellon Corp	315,267	$2.93M	0.0%	+1.9%	0.338%
5/11/2022	JPMorgan Chase & Co.	8,189,899	$76.09M	0.0%	+10.4%	8.768%
5/11/2022	GSA Capital Partners LLP	14,466	$0.13M	0.0%	-40.7%	0.015%
5/10/2022	ProShare Advisors LLC	25,931	$0.24M	0.0%	-17.5%	0.028%
5/10/2022	Fox Run Management L.L.C.	23,953	$0.22M	0.1%	N/A	0.026%
5/9/2022	Swiss National Bank	177,700	$1.65M	0.0%	+12.5%	0.190%
5/9/2022	Teacher Retirement System of Texas	15,447	$0.14M	0.0%	+12.6%	0.017%
5/9/2022	Qube Research & Technologies Ltd	23,670	$0.22M	0.0%	N/A	0.025%
5/6/2022	Sector Gamma AS	123,713	$1.15M	0.2%	N/A	0.132%
5/5/2022	New York State Common Retirement Fund	64,445	$0.60M	0.0%	+11.5%	0.069%
5/5/2022	Pinnacle Associates Ltd.	429,766	$3.99M	0.1%	-4.4%	0.460%
5/4/2022	Envestnet Asset Management Inc.	12,045	$0.11M	0.0%	N/A	0.013%
4/29/2022	SG Americas Securities LLC	206,374	$1.92M	0.0%	-5.5%	0.233%
4/28/2022	DekaBank Deutsche Girozentrale	31,200	$0.29M	0.0%	+9.9%	0.035%
4/26/2022	Hennion & Walsh Asset Management Inc.	156,559	$1.45M	0.1%	+24.7%	0.177%
4/25/2022	Assenagon Asset Management S.A.	729,686	$6.78M	0.0%	-62.6%	0.825%
3/11/2022	Bradley Foster & Sargent Inc. CT	16,581	$0.26M	0.0%	N/A	0.019%
2/23/2022	Barclays PLC	233,192	$3.68M	0.0%	-23.1%	0.264%
2/16/2022	Wasatch Advisors Inc.	2,025,516	$31.92M	0.1%	-30.3%	2.291%
2/14/2022	Canada Pension Plan Investment Board	182,000	$2.87M	0.0%	-5.7%	0.206%
2/14/2022	D. E. Shaw & Co. Inc.	919,401	$14.49M	0.0%	+10.5%	1.040%
2/14/2022	PDT Partners LLC	118,400	$1.87M	0.1%	+20.0%	0.134%
2/14/2022	Virtus ETF Advisers LLC	10,456	$0.17M	0.1%	-27.9%	0.012%

Data available starting January 2016

Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferative disease, as well as hematologic and solid tumors, including nasopharyngeal carcinoma. The company is also developing next-generation CAR T immunotherapies for patients with hematologic malignancies and solid tumors, including ATA2271 and ATA3271 for mesothelin; and ATA2431 and ATA3219 for B-cell malignancies, as well as ATA188 for the treatment of multiple sclerosis. In addition, it develops ATA368 program for patients with human papillomavirus associated cancers. Atara Biotherapeutics, Inc. has a license agreement with Memorial Sloan Kettering Cancer Center; license, and research and development collaboration agreement with QIMR Berghofer Medical Research Institute; and strategic collaboration with H. Lee Moffitt Cancer Center, as well as Bayer AG for mesothelin-targeted CAR T-cell therapies for solid tumors. The company was incorporated in 2012 and is headquartered in South San Francisco, California.

Today's Range

Now: $4.94

$4.83

$5.34

50 Day Range

MA: $5.38

$2.85

$8.73

52 Week Range

Now: $4.94

$2.83

$20.04

Volume

2,131,607 shs

Average Volume

1,575,016 shs

Market Capitalization

$466.15 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.09

Who are the company insiders with the largest holdings of Atara Biotherapeutics?: Atara Biotherapeutics' top insider shareholders include:
Pascal Touchon (CEO)
Utpal Koppikar (CFO)
Jakob Dupont (EVP)
Joe Newell (COO)
Joe Newell (Insider)
Amar Murugan (SVP)
Kristin Yarema (Insider)
Matthew K Fust (Director)
Thomas Peterffy (Chairman)
Learn More about top insider investors at Atara Biotherapeutics.
Who are the major institutional investors of Atara Biotherapeutics?: Atara Biotherapeutics' top institutional investors include:
JPMorgan Chase & Co. — 9.39%
State Street Corp — 6.59%
FMR LLC — 6.20%
Eminence Capital LP — 1.40%
Northern Trust Corp — 0.92%
Healthcare of Ontario Pension Plan Trust Fund — 0.65%
Learn More about top institutional investors of Atara Biotherapeutics stock.
Which major investors are selling Atara Biotherapeutics stock?: In the previous quarter, ATRA stock was sold by these institutional investors:
Millennium Management LLC
Renaissance Technologies LLC
UBS Group AG
SG Americas Securities LLC
Assenagon Asset Management S.A.
Integral Health Asset Management LLC
State Street Corp
Eminence Capital LP
During the last year, company insiders that have sold Atara Biotherapeutics company stock include:
Pascal Touchon (CEO)
Utpal Koppikar (CFO)
Jakob Dupont (EVP)
Joe Newell (COO)
Joe Newell (Insider)
Amar Murugan (SVP)
Learn More investors selling Atara Biotherapeutics stock.
Which major investors are buying Atara Biotherapeutics stock?: Within the previous quarter, ATRA stock was bought by institutional investors including:
JPMorgan Chase & Co.
Healthcare of Ontario Pension Plan Trust Fund
Bank of Montreal Can
Staley Capital Advisers Inc.
FMR LLC
Thrivent Financial for Lutherans
Hennion & Walsh Asset Management Inc.
Ensign Peak Advisors Inc